A Big Boost for Northwest Cancer Clinic
A clinic in the Tri-Cities has received the green light for radiation clinical trials for prostate and lung cancer.
The Northwest Cancer Clinic enrolled its first two patients this week into a national clinical trial for prostate cancer.
The doctors have partnered with Virginia Mason Hospital to offer the National Cancer Institute endorsed clinical trials.
These trials are geared towards patients who have the cancer come back after surgery.
More than 300 institutions are working together to find cures for multiple cancers under this specific group of trials via the Radiation Therapy Oncology Group (RTOG).
Dr. Sheila Rege says what the approval means for patients in this area is more options for treatment, more specific treatments and ultimately a difference in a patient's quality of life..
"Cancer is not a single disease and it's not a one size fits all, one treatment is meant for everybody, solution. This is especially important if the cancer comes back, or it's not a common cancer, or there's a newer treatment out there. What we can offer here is a clinical trial, and that is very important because of access, and chances of better therapy," said Rege.
She also said the approval means the clinic could be approved for more clinical trials on other types of cancers in the future.
Doctors at Northwest say they are "especially excited about other RTOG trials that are open to see if holistic or organic products can help reduce side effects of chemotherapy and radiation. There is a trial looking at whether Manuka honey will help patients have less side effects even while undergoing cancer treatments."
The honey is provided free of charge to cancer patients from RTOG.
September is National Prostate Cancer Awareness Month.
There are 30 million American men living with some form of prostate-related diagnoses in the US.